616 A novel non-covalent linker peptide with nanomolar affinity for clinical IgG1 antibodies preserves antibody-antigen affinity and drug potency against PDL1+ melanoma when conjugated with DM1

• Svetomir Markovic,
• John Butterfield,
• Shari Sutor,
• Wendy Nevala

Affiliations

Svetomir Markovic

Aff1 grid.66875.3a000000040459167XMayo Clinic Rochester MN USA

John Butterfield

Mayo Clinic, Rochester, MN, USA

Shari Sutor

Mayo Clinic, Rochester, MN, USA

Wendy Nevala

Mayo Clinic, Rochester, MN, USA